Roth et. al reported that KRAS exon 2 mutation was related to tumor grade and MSI status in stage II-III colon cancers [7], but RAS mutations were not related to tumor grade or dMMR status in our series. This evidence concerns the gene KRAS and malignant colon neoplasm.